Thalidomide, a sedative that caused severe birth defects 50 years ago when it was prescribed to pregnant women, has enjoyed revived interest owing to its potency as an antiangiogenic and anti ...

Upon its 'reinvention', thalidomide was quickly applied to 'microenvironment-dependent' diseases such as multiple myeloma, yet its role in the solid tumor spectrum has not been validated.